DOI: https://doi.org/10.22263/2312-4156.2023.1.94
V.A. Malatok1, S.E. Rzheussky1, S.V. Hvozdzeu1, V.L. Denisenko1,2, S.А. Sushkov1
The evaluation of the safety of medical hemostatic foam based on aluminum and iron chlorides
1Vitebsk State Order of Peoples’ Friendship Medical University, Vitebsk, Republic of Belarus
2Vitebsk Regional Clinical Specialized Center, Vitebsk, Republic of Belarus
Vestnik VGMU. 2023;22(1):94-99.
Abstract.
The aim of this work was to determine the effect of the concentrations of aluminum chloride and iron (III) chloride in the medical foam of hemostatic action, prepared according to a previously developed technology, on the process of postoperative complications formation during the stopping of bleeding from parenchymal organs. On the third day after the simulation of parenchymal bleeding the following safety criteria for the use of the developed drug were studied on the liver of rats: the degree of inflammation, the number of adhesions formed, the thickness and prevalence of fibrin plaque, the presence of blood clots. In addition, the postoperative activity of the operated animals was monitored. In total, 9 compositions of medical foam were studied in the range of metal chloride concentrations from 0% to 15%. Each group included 4 outbred rats of both sexes. While studying postoperative complications after the use of a composition containing 5% aluminum chloride and 10% iron (III) chloride, it was found that this combination of substances produced a strong cauterizing effect on the liver wound. When using it, multiple adhesions, a thick spreading fibrin coating, and severe inflammation of the wound were observed. Medical foam containing aluminum chloride and iron (III) chloride at concentrations of 10% and 0% as active ingredients, on the contrary, was effective and didn’t cause any significant complications. Animals in this group had no adhesive, inflammatory processes and signs of bleeding recurrence, there was a thin layer of fibrin in the area of the liver wound. Based on the data obtained and previously conducted studies, the concentrations of the active ingredients of aluminum chloride 10% and iron (III) chloride 0% were selected for inclusion in the composition of the medicine being developed.
Keywords: medical foam, local hemostatic agents, aluminum chloride, iron (III) chloride, hemostatic effect, parenchymal bleeding.
Funding: Belarusian Republican Foundation for Basic Research. The research work was conducted within the frames of BRFFR grant “Science M” 2022 (agreement №M22M).
References
1. Marufkhonov ON. Possibilities of Cellulose Derived Film Coatings in Liver Surgery. Vestn Magistratury. 2019;(9-2):17-20. (In Russ.)
2. Lipatov VA, Abrosimova NV, Severinov DA, Ushanov AA. Study of morphological changes in the spleen after implantation of carboxymethylcellulose-based blood-stopping materials. V: Kurskii gos med un-t; Lazarenko VA, Lipatov VA, Lazarenko SV, redkol. Problemy gemostaza v khirurgii XXI veka: sb tr univ konf studentov i molodykh uchenykh, Kursk, 18–19 maya 2017 g. Kursk, RF; 2017. Р. 34-7. (In Russ.)
3. Davydenko VV, Vlasov TD, Dobroskok IN, Brazhnikova EN, Zabivalova NM. Comparative effectiveness of topical hemostatic agents applied to stop experimental parenchymal and arterial bleeding. Vestn Eksperim Klin Khirurgii. 2015;8(2):186-94. (In Russ.)
4. Soldatova DS, Bezhin AI, Litvinenko IV. Analysis of the effectiveness of single-component and combined hemostatic agents. Innova. 2019;(4):25-9. (In Russ.)
5. Ismailov BA, Sadykov RA, Kim OV. Hemostatic implant of cellulose derivatives. Eksperim Klin Gastroenterologiya. 2019;(169):56-61. (In Russ.)
6. Novitskaya VA, Rzheusskiy SE. Drugs of the group of tissue sealants in the pharmaceutical market of the Republic of Belarus. Vestn VGMU. 2021;20(4):67-74. (In Russ.)
7. Molotok VA, Rzheusskiy SE. Pharmaceutical development of medical styptic foam. Vestn Farmatsii. 2021;(4):22-5. (In Russ.)
8. Nauch tsentr ekspertizy sredstv med primeneniya Minzdravsotsrazvitiya Rossii; Mironov AN, red. Guidelines for conducting preclinical studies of drugs. Ch 1. Moscow, RF: Grif i K; 2012. 944 р. (In Russ.)
Information about authors:
V.A. Malatok – postgraduate of the Chair of Management & Marketing of Pharmacy, Vitebsk State Order of Peoples’ Friendship Medical University,
e-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. – Veranika A. Malatok;
S.E. Rzheussky – Candidate of Pharmaceutical Sciences, associate professor of the Chair of Management & Marketing of Pharmacy, Vitebsk State Order of Peoples’ Friendship Medical University;
S.V. Hvozdzeu – postgraduate of the Chair of General Surgery, Vitebsk State Order of Peoples’ Friendship Medical University;
V.L. Denisenko – Doctor of Medical Sciences, chief physician of the Vitebsk Regional Clinical Specialized Center; associate professor of the Chair of General Surgery, Vitebsk State Order of Peoples’ Friendship Medical University;
S.A. Sushkov – Candidate of Medical Sciences, associate professor of the Chair of General Surgery, Vitebsk State Order of Peoples’ Friendship Medical University.
